1. Home
  2. OKYO vs MCHX Comparison

OKYO vs MCHX Comparison

Compare OKYO & MCHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OKYO Pharma Limited

OKYO

OKYO Pharma Limited

HOLD

Current Price

$1.47

Market Cap

81.3M

Sector

Health Care

ML Signal

HOLD

Logo Marchex Inc. Class B

MCHX

Marchex Inc. Class B

HOLD

Current Price

$1.76

Market Cap

67.3M

ML Signal

HOLD

Company Overview

Basic Information
Metric
OKYO
MCHX
Founded
2007
2003
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
81.3M
67.3M
IPO Year
2021
2003

Fundamental Metrics

Financial Performance
Metric
OKYO
MCHX
Price
$1.47
$1.76
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$6.33
N/A
AVG Volume (30 Days)
160.4K
21.9K
Earning Date
07-18-2025
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$90,291,000.00
Revenue This Year
N/A
$5.37
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.34
$1.32
52 Week High
$3.35
$2.14

Technical Indicators

Market Signals
Indicator
OKYO
MCHX
Relative Strength Index (RSI) 46.71 58.55
Support Level $1.45 $1.55
Resistance Level $1.72 $1.92
Average True Range (ATR) 0.12 0.11
MACD -0.01 -0.00
Stochastic Oscillator 29.40 66.67

Price Performance

Historical Comparison
OKYO
MCHX

About OKYO OKYO Pharma Limited

OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.

About MCHX Marchex Inc. Class B

Marchex Inc provides AI-based conversational intelligence and analytics solutions that generate insights from customer communications data. The company's products support sales, marketing, and executive teams in analyzing customer interactions across communication channels and informing business decisions. It serves companies operating in business-to-business-to-consumer (B2B2C) markets across multiple industries like automotive, home services, healthcare, real estate, and advertising. The company operates in a single segment: conversational analytics and related solutions. The company generates the majority of revenue from its conversational intelligence product offerings. Geographically, it generates the maximum revenue from the United States.

Share on Social Networks: